Antidiabetic Effect of Interleukin-1β Antibody Therapy Through β-Cell Protection in the Cohen Diabetes-Sensitive Rat

Aharon-Hananel, Genya; Jörns, Anne; Lenzen, Sigurd; Raz, Itamar; Weksler-Zangen, Sarah
May 2015
Diabetes;May2015, Vol. 64 Issue 5, p1780
Academic Journal
Interleukin (IL)-1β, the sole proinflammatory cytokine released from pancreas-infiltrating macrophages, inhibits glucose-stimulated insulin secretion (GSIS), causing hy-perglycemia in Cohen diabetes-sensitive (CDs) rats fed a diabetogenic-diet (CDs-HSD). Because IL-1β blockade is a potential therapeutic target in diabetes, we examined whether treating CDs rats with IL-1β antibody (IL-1βAb; 0.5 mg/kg body weight) could counteract the inhibition of GSIS and hyperglycemia. We found that daily IL-1βAb injections had a beneficial effect on glucose tolerance and insulin secretion in CDs-HSD rats. In the oral glucose tolerance test, IL-1βAb-treated CDs-HSD rats showed lower blood glucose concentrations (P < 0.001) and higher GSIS (P < 0.05) compared with nontreated CDs-HSD rats. IL-1βAb treatment also protected the exocrine pancreas; the number of infiltrating macrophages decreased by 70% (P < 0.01) and IL-1β expression decreased by 85% (P < 0.01). In parallel, a 50% reduction (P < 0.01) in the rate of apoptosis and in fat infiltration (P < 0.05) was noted in the exocrine parenchyma of IL-1βAb-treated CDs-HSD rats compared with nontreated CDs-HSD rats. Altogether, these data demonstrate that blocking IL-1β action by IL-1βAb counteracted β-cell dysfunction and glucose intolerance, supporting the notion that prevention of pancreas infiltration by macrophages producing IL-1β is of crucial importance for the preservation of β-cell function and prevention of diabetes.


Related Articles

  • Pancreatic Alpha-Cell Dysfunction Contributes to the Disruption of Glucose Homeostasis and Compensatory Insulin Hypersecretion in Glucocorticoid-Treated Rats. Rafacho, Alex; Gonçalves-Neto, Luiz M.; Santos-Silva, Junia C.; Alonso-Magdalena, Paloma; Merino, Beatriz; Taboga, Sebastião R.; Carneiro, Everardo M.; Boschero, Antonio C.; Nadal, Angel; Quesada, Ivan // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Glucocorticoid (GC)-based therapies can cause insulin resistance (IR), glucose intolerance, hyperglycemia and, occasionally, overt diabetes. Understanding the mechanisms behind these metabolic disorders could improve the management of glucose homeostasis in patients undergoing GC treatment. For...

  • Quercetin Stimulates Insulin Secretion and Reduces the Viability of Rat INS-1 Beta-Cells. Kittl, Michael; Beyreis, Marlena; Tumurkhuu, Munkhtuya; Fürst, Johannes; Helm, Katharina; Pitschmann, anna; Gaisberger, Martin; Glasl, Sabine; Ritter, Markus; Jakab, Martin // Cellular Physiology & Biochemistry (Karger AG);Jul2016, Vol. 39 Issue 1, p278 

    Background/Aims: Previously we described insulinotropic effects of Leonurus sibiricus L. plant extracts used for diabetes mellitus treatment in Traditional Mongolian Medicine. The flavonoid quercetin and its glycoside rutin, which exert anti-diabetic properties in vivo by interfering with...

  • Beta-cell function improved by supplementing basal insulin secretion in mild diabetes. Turner, R.C.; McCarthy, S.T.; Holman, R.R.; Harris, E. // British Medical Journal;5/22/1976, Vol. 1 Issue 6020, p1252 

    Examines the function of improved beta-cell by supplementing basal insulin secretion in mild diabetes. Use of human insulin standard in measuring plasma human insulin; Feature of mild diabetes; Causes of prolonged hyperglycemia.

  • Association of IL-1ra and Adiponectin With C-Peptide and Remission in Patients With Type 1 Diabetes. Pfleger, Christian; Mortensen, Henrik B.; Hansen, Lars; Herder, Christian; Roep, Bart O.; Hoey, Hillary; Aanstoot, Henk-Jan; Kocova, Mirjana; Schloot, Nanette C. // Diabetes;Apr2008, Vol. 57 Issue 4, p929 

    OBJECTIVE--We investigated the association of anti-inflammatory cytokine interleukin (IL)-1 receptor antagonist (IL-1ra), adiponectin, proinflammatory cytokines IL-1β, IL-6, and CCL2, and tumor necrosis factor-α with β-cell function, metabolic status, and clinical remission in patients...

  • Preventing Type 2 Diabetes Mellitus: Room for Residual Risk Reduction After Lifestyle Changes? Athyros, V. G.; Tziomalos, K.; Karagiannis, A.; Mikhailidis, D. P. // Current Pharmaceutical Design;11/30/2010, Vol. 16 Issue 34, p3839 

    No abstract available.

  • Transgenic Overexpression of Active Calcineurin in β-Cells Results in Decreased β-Cell Mass and Hyperglycemia. Bernal-Mizrachi, Ernesto; Cras-Méneur, Corentin; Ye, Bo Ra; Johnson, James D.; Permutt, M. Alan // PLoS ONE;2010, Vol. 5 Issue 8, p1 

    Background: Glucose modulates β-cell mass and function through an initial depolarization and Ca2+ influx, which then triggers a number of growth regulating signaling pathways. One of the most important downstream effectors in Ca2+ signaling is the calcium/Calmodulin activated serine threonine...

  • Low Concentration of Interleukin-1β Induces FLICE-Inhibitory Protein-Mediated β-Cell Proliferation in Human Pancreatic Islets. Maedler, Kathrin; Schumann, Desiree M.; Sauter, Nadine; Ellingsgaard, Helga; Bosco, Domenico; Baertschiger, Reto; Iwakura, Yoichiro; Oberholzer, José; Wollheim, Claes B.; Gauthier, Benoit R.; Donath, Marc Y. // Diabetes;Oct2006, Vol. 55 Issue 10, p2713 

    High glucose concentrations have a dual effect on β-cell turnover, inducing proliferation in the short-term and apoptosis in the long-term. Hyperglycemia leads to β-cell production of interleuking (IL)-1β in human pancreatic islets. Fas, a death receptor regulated by IL-1β, is...

  • Amyloid and the Macrophage: It's All About Local Production of IL-1β. Broniowska, Katarzyna A.; Corbett, John A. // Diabetes;May2014, Vol. 63 Issue 5, p1448 

    The authors comment on a study published in this issue of the journal which investigated the role of amyloid polypeptide in stimulating the local production of interleukin-1 (IL-1) in islets. Particular focus is given to the effect of IL-1 on pancreatic β-cell function, as well as the link...

  • IAPP boosts islet macrophage IL-1 in type 2 diabetes. Mandrup-Poulsen, Thomas // Nature Immunology;Oct2010, Vol. 11 Issue 10, p881 

    The article discusses the islet amyloid polypeptide (IAPP), a hormone deposited in the pancreatic islets, and its ability to induct macrophage processing of interleukin 1 (IL-1) linked to beta-cell destruction in type 2 diabetes. It says that there is a direct evidence of IAPP-induced activation...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics